Cargando…
Bcl‐2 hijacks the arsenic trioxide resistance in SH‐SY5Y cells
Aresenic trioxide (ATO) is proven to be active against leukaemia cells by inducing apoptosis and differentiation. Even though ATO could effectively induce remissions of leukaemia cells, the drug resistance was observed occasionally. To further dissect the mechanism of ATO resistance, we selected the...
Autores principales: | Wang, Jinling, Peng, Xiaohui, Yang, Daowei, Guo, Mengyu, Xu, Xiao, Yin, Fengyue, Wang, Yu, Huang, Jiaqing, Zhan, Linghui, Qi, Zhongquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743673/ https://www.ncbi.nlm.nih.gov/pubmed/34910369 http://dx.doi.org/10.1111/jcmm.17128 |
Ejemplares similares
-
Arsenic trioxide induces gasdermin E mediated pyroptosis in astroglioma cells
por: Wang, Jingling, et al.
Publicado: (2020) -
Arsenic trioxide induces cell cycle arrest and affects Trk receptor expression in human neuroblastoma SK-N-SH cells
por: Xiong, Xilin, et al.
Publicado: (2018) -
Arsenic induces the global hypophosphorylation of insulin receptor substrate proteins in differentiated human neuroblastoma SH-SY5Y cells
por: Wisessaowapak, Churaibhon, et al.
Publicado: (2023) -
Protective effects of curcumin in APPswe transfected SH-SY5Y cells★
por: Yin, Wenke, et al.
Publicado: (2012) -
miR‐34a/BCL‐2 signaling axis contributes to apoptosis in MPP(+)‐induced SH‐SY5Y cells
por: Shanesazzade, Zahra, et al.
Publicado: (2018)